| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/26/1997 | US5660812 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 08/26/1997 | CA2111463C Azaspiro quinolone antibacterial agents |
| 08/26/1997 | CA1339387C Magainins-synthetic antimicrobial compounds |
| 08/26/1997 | CA1339373C 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030082A2 Antifungic and antibacterial peptide |
| 08/21/1997 | WO1997030081A1 Ebna2 peptides and methods of using same |
| 08/21/1997 | WO1997030078A1 DERIVATIVES OF ANTIBIOTIC GE2270 FACTORS C2a, D2 AND E |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 08/21/1997 | WO1997030029A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 08/21/1997 | WO1997030027A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | WO1997029772A1 Recombinant canine herpesviruses |
| 08/21/1997 | WO1997029757A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | WO1997029751A1 Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997029741A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials |
| 08/21/1997 | WO1997029733A1 Compositions containing an antifungal and a sulfur compound |
| 08/21/1997 | WO1997029645A1 Animal feed |
| 08/21/1997 | WO1997029630A1 A method of preventing animals from diseases and improving immune function of animals |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | CA2246503A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2245964A1 Animal feed |
| 08/21/1997 | CA2245830A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | CA2245518A1 Antifungic and antibacterial peptide |
| 08/21/1997 | CA2243662A1 Recombinant canine herpesviruses |
| 08/21/1997 | CA2242067A1 Derivatives of antibiotic ge2270 factors c2a, d2 and e |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | CA2216465A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790057A1 Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
| 08/20/1997 | EP0789768A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
| 08/20/1997 | EP0789767A1 Purified papillomavirus proteins |
| 08/20/1997 | EP0789766A1 Chimeric papillomavirus-like particles |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789754A1 H. pylori fermentation process |
| 08/20/1997 | EP0789715A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/20/1997 | EP0789707A1 Amino acid nucleic acids |
| 08/20/1997 | EP0789706A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/20/1997 | EP0789697A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| 08/20/1997 | EP0789695A2 Thiepane compounds inhibiting and detecting hiv protease |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789581A1 Method for the prevention and treatment of bovine mastitis |
| 08/20/1997 | EP0789579A1 Aza cyclohexapeptide compounds |
| 08/20/1997 | EP0789564A1 Polynucleotide compositions |
| 08/20/1997 | EP0789563A1 Hepatitis virus vaccines |
| 08/20/1997 | EP0789553A1 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 08/20/1997 | EP0701571B1 Antibody fragments in therapy |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157611A Novel quinolone 5-(N-heterosubstituted amino) antimicrobials |
| 08/20/1997 | CN1157610A Thiopyridyl compounds for controlling helicobacter bacteria |
| 08/20/1997 | CN1157564A Method of treating opportunistic infections with azaspiranes |
| 08/19/1997 | US5659038 Grampositive/gramnegative microbiocides; antiseptics, human and veterinary medicine |
| 08/19/1997 | US5659030 Antibiotic drug in crystal form |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658909 Inhibition of abnormally phosphorylated paired helical filament epitope formation |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658898 Intravenous solutions for a derivative of staurosporine |
| 08/19/1997 | US5658891 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 08/19/1997 | US5658887 Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite |
| 08/19/1997 | US5658880 Prevent selectin binding; antiinflammatory, anticancer agents; aids therapy |
| 08/19/1997 | US5658803 For diagnosis, prophylaxis, treatment of bacterial infections |
| 08/19/1997 | CA1339313C Pyrimidine derivatives |
| 08/19/1997 | CA1339301C2 Antibacterial antiplaque, anticalculus oral composition |
| 08/14/1997 | WO1997029185A1 Recombinant phages |
| 08/14/1997 | WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029111A1 New cephem compounds and pharmaceutical use thereof |
| 08/14/1997 | WO1997028826A2 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | WO1997028820A1 Vaccines against varicella zoster virus gene 63 product |
| 08/14/1997 | WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | WO1997028802A1 Inhibition of viral replication |
| 08/14/1997 | WO1997028795A1 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections |
| 08/14/1997 | DE19606355A1 Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung Contraceptive delivery systems with antiviral and / or antibacterial effect |
| 08/14/1997 | CA2245920A1 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | CA2244848A1 Inhibition of viral replication |
| 08/14/1997 | CA2244792A1 Recombinant phages |
| 08/14/1997 | CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789026A1 Hetero-aryl oxazolidinone and their use as antibacterial medicine |
| 08/13/1997 | EP0789025A1 Substituted oxazolidinone and their use as antibacterial medicine |
| 08/13/1997 | EP0788798A1 Antiviral agent and process for preparing the same |
| 08/13/1997 | EP0788797A1 Use of PHMB for the treatment of infections caused by intracellularly propagating germs |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788511A1 Cyclic hexapeptides having antibiotic activity |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788507A1 L-pyranosyl nucleosides |
| 08/13/1997 | EP0788501A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/13/1997 | EP0788498A1 Phenyloxazolidinone antimicrobials |
| 08/13/1997 | EP0788495A2 L-erythrosyl nucleosides |
| 08/13/1997 | EP0788372A1 Attenuated canine parvovirus vaccine |